Search Results - "Forte, Serene"
-
1
Early- and Intermediate-Stage Variants of Simian Immunodeficiency Virus Replicate Efficiently in Cells Lacking CCR5
Published in Journal of Virology (01-09-2003)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
2
Attenuation of human immunodeficiency virus type 1 cytopathic effects by replacing a 424-bp region of envelope from a noncytopathic biological clone
Published in AIDS research and human retroviruses (20-01-2000)“…We analyzed the env genes of cytopathic and noncytopathic biological clones derived from two HIV-1-infected children with discordant clinical courses. Chimeric…”
Get more information
Journal Article -
3
Anti-arthritic effects demonstrated by an interleukin-2 receptor-targeted cytotoxin (DAB486IL-2) in rat adjuvant arthritis
Published in European journal of immunology (01-07-1992)“…DAB486IL-2 is an interleukin-2 receptor-specific cytotoxin which selectively targets and kills cells which bear the high-affinity form of the IL-2 receptor…”
Get more information
Journal Article -
4
In vitro characterization of HIV type 1 biological clones from asymptomatic and symptomatic pediatric patients
Published in AIDS research and human retroviruses (20-11-1996)“…To investigate the mechanisms of HIV-1 cytopathogenicity, functional biological HIV-1 clones were isolated from two infected children with high viral loads in…”
Get more information
Journal Article -
5
Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin-related interleukin-2 fusion protein
Published in Transplantation (01-02-1989)“…A diphtheria toxin-related IL-2 fusion gene has been constructed that encodes a 68KD recombinant toxin in which the diphtheria toxin receptor-binding domain…”
Get more information
Journal Article -
6
Impact of interleukin-2-receptor-targeted cytotoxins on a unique model of murine interleukin-2-receptor-expressing malignancy
Published in International journal of cancer (19-08-1991)“…DAB486IL-2 is a genetically engineered fusion protein consisting of a portion of diphtheria toxin fused to human IL-2. It is specifically cytotoxic for tumor…”
Get more information
Journal Article -
7
Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells
Published in AIDS research and human retroviruses (01-12-1994)“…Human immunodeficiency virus type 1 (HIV-1) isolates from six infected individuals less then 4 years of age were phenotyped for their syncytium-inducing (SI)…”
Get more information
Journal Article -
8
Amyotrophic lateral sclerosis: thyrotropin-releasing hormone and histidyl proline diketopiperazine in the spinal cord and cerebrospinal fluid
Published in Neurology (01-09-1986)“…In spinal cords from seven amyotrophic lateral sclerosis (ALS) patients and four controls, we found no difference in thyrotropin-releasing hormone (TRH)…”
Get full text
Journal Article -
9
Pharmacokinetics of the recombinant fusion protein DAB486IL-2 in animal models
Published in Cancer chemotherapy and pharmacology (01-01-1990)“…The kinetics of the in vitro cytotoxicity of DAB486IL-2, a genetically engineered fusion protein containing a portion of diphtheria toxin and human…”
Get full text
Journal Article